v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
BioLargo Energy Technologies, Inc (BETI) [Member]
Common Stock [Member]
BioLargo Energy Technologies, Inc (BETI) [Member]
Additional Paid-in Capital [Member]
BioLargo Energy Technologies, Inc (BETI) [Member]
Retained Earnings [Member]
BioLargo Energy Technologies, Inc (BETI) [Member]
AOCI Attributable to Parent [Member]
BioLargo Energy Technologies, Inc (BETI) [Member]
Noncontrolling Interest [Member]
BioLargo Energy Technologies, Inc (BETI) [Member]
Clyra Medical Technologies [Member]
Clyra Medical Preferred Stock, Series B [Member]
Common Stock [Member]
Clyra Medical Technologies [Member]
Clyra Medical Preferred Stock, Series B [Member]
Additional Paid-in Capital [Member]
Clyra Medical Technologies [Member]
Clyra Medical Preferred Stock, Series B [Member]
Retained Earnings [Member]
Clyra Medical Technologies [Member]
Clyra Medical Preferred Stock, Series B [Member]
AOCI Attributable to Parent [Member]
Clyra Medical Technologies [Member]
Clyra Medical Preferred Stock, Series B [Member]
Noncontrolling Interest [Member]
Clyra Medical Technologies [Member]
Clyra Medical Preferred Stock, Series B [Member]
Clyra Medical Technologies [Member]
Common Stock [Member]
Clyra Medical Technologies [Member]
Additional Paid-in Capital [Member]
Clyra Medical Technologies [Member]
Retained Earnings [Member]
Clyra Medical Technologies [Member]
AOCI Attributable to Parent [Member]
Clyra Medical Technologies [Member]
Noncontrolling Interest [Member]
Clyra Medical Technologies [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2023                                     292,945,747          
Balance at Dec. 31, 2023                                     $ 196,000 $ 154,023,000 $ (147,098,000) $ (277,000) $ (2,642,000) $ 4,202,000
Stock for cash, net offering costs (in shares)                                     2,614,895          
Stock for cash, net offering costs                                     $ 2,000 592,000 0 0 0 $ 594,000
Issuance of stock for services (in shares)                                     1,107,594         1,107,594
Issuance of stock for services                                     $ 1,000 283,000 0 0 0 $ 284,000
Issuance of common stock in exchange for BETI shares (in shares) 378,788                                              
Issuance of common stock in exchange for BETI shares $ 0 $ 0 $ 0 $ 0 $ 0 $ 0                                    
Warrant exercise (in shares)                                     3,278,337          
Warrant exercise                                     $ 3,000 753,000 0 0 0 756,000
Stock option compensation expense                                     $ 0 1,535,000 0 0 0 1,535,000
Stock option exercise (in shares)                                     948,882          
Stock option exercise                                     $ 0 153,000 0 0 0 153,000
Clyra Medical stock option compensation expense                         $ 0 $ 0 $ 0 $ 0 $ 528,000 $ 528,000            
Clyra Medical stock issued for services                         0 0 0 0 132,000 132,000            
Clyra Medical dividend Series A Preferred stock                         0 0 0 0 (345,000) (345,000)            
Clyra Medical warrant exercise                         0 0 0 0 30,000 30,000            
Clyra Medical warrant fee                         0 0 0 0 106,000 106,000            
Clyra Medical stock unit offering                         0 0 0 0 2,005,000 2,005,000            
Clyra Medical conversion of note payable and interest                         0 0 0 0 119,000 119,000            
Clyra Medcial fair value of warrants issued with note payable                         0 0 0 0 160,000 160,000            
BETI unit offering $ 0 0 0 0 50,000 50,000                                    
Noncontrolling interest allocation                                     0 993,000 0 0 (993,000) 0
Net loss                                     0 0 (2,402,000) 0 (1,945,000) (4,347,000)
Foreign currency translation adjustment                                     $ 0 0 0 94,000 0 94,000
Balance (in shares) at Dec. 31, 2024                                     301,274,243          
Balance at Dec. 31, 2024                                     $ 202,000 158,332,000 (149,500,000) (183,000) (2,795,000) 6,056,000
Stock for cash, net offering costs (in shares)                                     12,876,702          
Stock for cash, net offering costs                                     $ 9,000 2,018,000 0 0 0 $ 2,027,000
Issuance of stock for services (in shares)                                     2,807,771         2,807,771
Issuance of stock for services                                     $ 2,000 555,000 0 0 0 $ 557,000
Issuance of common stock in exchange for BETI shares (in shares) 153,261                                              
Issuance of common stock in exchange for BETI shares $ 0 0 0 0 0 0                                    
Stock option compensation expense                                     $ 0 1,762,000 0 0 0 1,762,000
Stock option exercise (in shares)                                     265,800          
Stock option exercise                                     $ 0 0 0 0 0 0
Clyra Medical stock option compensation expense                         0 0 0 0 1,203,000 1,203,000            
Clyra Medical stock issued for services                         0 0 0 0 76,000 76,000            
Clyra Medical dividend Series A Preferred stock                         0 0 0 0 (347,000) (347,000)            
Clyra Medical stock unit offering             $ 0 $ 0 $ 0 $ 0 $ 2,145,000 $ 2,145,000 0 0 0 0 445,000 445,000            
Clyra Medcial fair value of warrants issued with note payable                         0 0 0 0 231,000 231,000            
BETI unit offering 0 0 0 0 425,000 425,000                                    
Noncontrolling interest allocation                                     0 2,649,000 0 0 (2,649,000) 0
Net loss                                     0 0 (11,780,000) 0 (3,409,000) (15,189,000)
Foreign currency translation adjustment                                     $ 0 0 0 (24,000) 0 (24,000)
Clyra Medical stock issued to convert debt                         0 0 0 0 250,000 250,000            
Clyra Medical Unit Warrant offering                         $ 0 $ 0 $ 0 $ 0 $ 1,894,000 $ 1,894,000            
BETI stock issued for services $ 0 $ 0 $ 0 $ 0 $ 15,000 $ 15,000                                    
Balance (in shares) at Dec. 31, 2025                                     317,377,777          
Balance at Dec. 31, 2025                                     $ 213,000 $ 165,316,000 $ (161,280,000) $ (207,000) $ (2,516,000) $ 1,526,000